ZNF594

gene
On this page

Also known as KIAA1871

Summary

ZNF594 (zinc finger protein 594, HGNC:29392) is a protein-coding gene on chromosome 17p13.2, encoding Zinc finger protein 594 (Q96JF6). May be involved in transcriptional regulation.

Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm.

Source: NCBI Gene 84622 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 151 total
  • MANE Select transcript: NM_032530

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29392
Approved symbolZNF594
Namezinc finger protein 594
Location17p13.2
Locus typegene with protein product
StatusApproved
AliasesKIAA1871
Ensembl geneENSG00000180626
Ensembl biotypeprotein_coding
Entrez84622

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000399604, ENST00000575779, ENST00000576772, ENST00000851805

RefSeq mRNA: 1 — MANE Select: NM_032530 NM_032530

CCDS: CCDS42241

Canonical transcript exons

ENST00000575779 — 2 exons

ExonStartEnd
ENSE0000153930751917485191868
ENSE0000265865951795355184276

Expression profiles

Bgee: expression breadth ubiquitous, 186 present calls, max score 81.46.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.8601 / max 39.6096, expressed in 1377 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1640203.86011377

Top tissues by expression

252 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534381.46gold quality
ganglionic eminenceUBERON:000402380.75gold quality
ventricular zoneUBERON:000305380.68gold quality
calcaneal tendonUBERON:000370180.29gold quality
sural nerveUBERON:001548879.80gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.31gold quality
left ovaryUBERON:000211976.35gold quality
right ovaryUBERON:000211875.55gold quality
adrenal tissueUBERON:001830375.54gold quality
right uterine tubeUBERON:000130274.94gold quality
ovaryUBERON:000099274.89gold quality
right hemisphere of cerebellumUBERON:001489074.81gold quality
cardiac muscle of right atriumUBERON:000337974.41gold quality
left ventricle myocardiumUBERON:000656674.19gold quality
cerebellar hemisphereUBERON:000224574.11gold quality
cerebellar cortexUBERON:000212974.00gold quality
gastrocnemiusUBERON:000138873.95gold quality
pituitary glandUBERON:000000773.90gold quality
right lobe of thyroid glandUBERON:000111973.76gold quality
muscle of legUBERON:000138373.49gold quality
adenohypophysisUBERON:000219673.42gold quality
body of uterusUBERON:000985373.26gold quality
left lobe of thyroid glandUBERON:000112073.05gold quality
stromal cell of endometriumCL:000225573.04gold quality
thyroid glandUBERON:000204672.97gold quality
metanephros cortexUBERON:001053372.93gold quality
vermiform appendixUBERON:000115472.91gold quality
cerebellumUBERON:000203772.75gold quality
muscle layer of sigmoid colonUBERON:003580572.45gold quality
smooth muscle tissueUBERON:000113572.44gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-8060yes299.62
E-MTAB-6058no40.68
E-ANND-3no2.87

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

113 targeting ZNF594, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-188-3P100.0068.761240
HSA-MIR-4262100.0073.263931
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-4768-5P100.0069.492861
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-5692A100.0074.406850
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-548P99.9872.253784
HSA-MIR-1229-3P99.9766.49906
HSA-MIR-448799.9664.581252
HSA-MIR-6845-3P99.9466.881439
HSA-MIR-311999.9271.342390
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-454-3P99.9174.011925
HSA-MIR-129799.9173.413162
HSA-MIR-130599.9171.433443
HSA-MIR-449399.9066.48977
HSA-MIR-366699.9073.241833
HSA-MIR-130A-3P99.9073.311861
HSA-MIR-130B-3P99.9073.271850
HSA-MIR-301A-3P99.9073.151839
HSA-MIR-301B-3P99.9073.191836
HSA-MIR-429599.9073.111838
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-808799.9069.551351
HSA-MIR-430299.8967.941187

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
danio_reriozgc:66472ENSDARG00000075916
drosophila_melanogastermldFBGN0263490

Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973), ZNF688 (ENSG00000229809)

Protein

Protein identifiers

Zinc finger protein 594Q96JF6 (reviewed: Q96JF6)

Alternative names: Zinc finger protein HZF18

All UniProt accessions (2): Q96JF6, I3L508

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (1): NP_115919* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096

UniProt features (29 total): zinc finger region 24, sequence variant 3, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96JF6-F169.260.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 52 (showing top): ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MARTENS_TRETINOIN_RESPONSE_DN, HES2_TARGET_GENES, HHEX_TARGET_GENES, RBM34_TARGET_GENES, SNIP1_TARGET_GENES, ZNF524_TARGET_GENES, MIR4262, MIR6809_3P, MIR181A_5P_MIR181B_5P, MIR181D_5P, MIR181C_5P, MIR6833_3P, MIR4492

GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)

GO Molecular Function (3): DNA binding (GO:0003677), zinc ion binding (GO:0008270), metal ion binding (GO:0046872)

GO Cellular Component (2): nucleus (GO:0005634), nucleoplasm (GO:0005654)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
nucleic acid binding1
transition metal ion binding1
cation binding1
intracellular membrane-bounded organelle1
nuclear lumen1
cellular anatomical structure1

Protein interactions and networks

STRING

476 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF594CAPN15O75808535
ZNF594MED8Q96G25479
ZNF594ETV7Q9Y603462
ZNF594RNF157Q96PX1447
ZNF594TFB2MQ9H5Q4443
ZNF594ZNF236Q9UL36417
ZNF594PPANQ9NQ55398
ZNF594DOT1LQ8TEK3390
ZNF594MAMLD1Q13495386
ZNF594FRG2CA6NGY1370
ZNF594A0A0B4J1V8A0A0B4J1V8364
ZNF594ZNF862O60290352
ZNF594MSH3P20585350
ZNF594C2CD4CQ8TF44349
ZNF594EPHB2P29323349

IntAct

8 interactions, top by confidence:

ABTypeScore
ZNF594ECE1psi-mi:“MI:0915”(physical association)0.370
NOTCH2ZNF320psi-mi:“MI:0914”(association)0.350
LTBP2ZNF320psi-mi:“MI:0914”(association)0.350
ANKRD36BCCDC66psi-mi:“MI:0914”(association)0.350
FBLN2ZNF316psi-mi:“MI:0914”(association)0.350
FMR1ZNF594psi-mi:“MI:0915”(physical association)0.000
ZNF594GOLGA2psi-mi:“MI:0915”(physical association)0.000

BioGRID (8): ZNF594 (Affinity Capture-MS), GOLGA2 (Two-hybrid), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-MS), ZNF594 (Affinity Capture-RNA)

ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

151 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance136
Likely benign12
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

84 predictions. Top by Δscore:

VariantEffectΔscore
17:5184161:ACATT:Adonor_gain0.9600
17:5184162:CATTC:Cdonor_gain0.9600
17:5184165:T:Adonor_gain0.9600
17:5184161:A:ACdonor_gain0.8600
17:5184162:C:CCdonor_gain0.8600
17:5184157:A:ACdonor_gain0.8200
17:5184158:C:CCdonor_gain0.8200
17:5184162:CATT:Cdonor_gain0.8000
17:5183142:T:TAdonor_gain0.6800
17:5184214:T:TAdonor_gain0.6200
17:5184163:A:Cdonor_gain0.5900
17:5184382:C:Adonor_gain0.5800
17:5184156:A:Tdonor_gain0.5300
17:5184381:T:Adonor_gain0.5300
17:5183657:T:TAdonor_gain0.5200
17:5184156:A:ATdonor_gain0.4900
17:5183654:ATGT:Adonor_gain0.4700
17:5183801:ATTT:Adonor_gain0.4100
17:5184158:CTCA:Cdonor_gain0.4100
17:5184155:TAAC:Tdonor_gain0.4000
17:5184155:TA:Tdonor_gain0.3600
17:5184158:C:Gdonor_gain0.3600
17:5184113:CCAG:Cdonor_gain0.3500
17:5184155:TAA:Tdonor_loss0.3500
17:5184156:AACT:Adonor_loss0.3500
17:5184157:A:Tdonor_loss0.3500
17:5184158:C:CAdonor_loss0.3500
17:5184159:T:TCdonor_gain0.3500
17:5184159:TCACA:Tdonor_loss0.3500
17:5184160:C:CCdonor_gain0.3500

AlphaMissense

5446 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:5182850:A:CF469L0.997
17:5182850:A:TF469L0.997
17:5182852:A:GF469L0.997
17:5182274:G:CF661L0.996
17:5182274:G:TF661L0.996
17:5182276:A:GF661L0.996
17:5182766:G:CF497L0.994
17:5182766:G:TF497L0.994
17:5182768:A:GF497L0.994
17:5183018:G:CF413L0.993
17:5183018:G:TF413L0.993
17:5183020:A:GF413L0.993
17:5182190:G:CF689L0.992
17:5182190:G:TF689L0.992
17:5182192:A:GF689L0.992
17:5182934:A:CF441L0.992
17:5182934:A:TF441L0.992
17:5182936:A:GF441L0.992
17:5182326:C:GR644P0.991
17:5183001:A:GL419P0.991
17:5182902:C:GR452P0.990
17:5182917:A:GL447P0.990
17:5182442:G:CF605L0.989
17:5182442:G:TF605L0.989
17:5182444:A:GF605L0.989
17:5182358:A:CF633L0.988
17:5182358:A:TF633L0.988
17:5182360:A:GF633L0.988
17:5182823:G:CH478Q0.988
17:5182823:G:TH478Q0.988

dbSNP variants (sampled 300 via entrez): RS1000264797 (17:5186237 G>A,C), RS1000471323 (17:5191959 C>T), RS1000574711 (17:5187326 A>G), RS1000605931 (17:5187080 T>A), RS1000719030 (17:5177197 T>A), RS1000767162 (17:5179550 T>A,C), RS1000837558 (17:5175434 A>T), RS1001002256 (17:5193752 A>G), RS1001038827 (17:5180609 G>C), RS1001074231 (17:5193312 C>A,T), RS1001088811 (17:5186488 C>T), RS1001137032 (17:5179860 A>G), RS1001361065 (17:5179571 A>G), RS1001370846 (17:5179280 G>A), RS1001494822 (17:5189103 A>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
Air Pollutantsdecreases expression, affects expression, increases abundance3
Valproic Acidaffects expression, increases expression3
sodium arseniteaffects cotreatment, increases abundance, increases expression, decreases expression2
Arsenicaffects methylation, affects cotreatment, increases abundance, increases expression2
Cyclosporinedecreases expression, increases methylation2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
GSK-J4decreases expression1
TAK-243increases sumoylation1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
trichostatin Aincreases expression1
manganese chlorideincreases abundance, increases expression, affects cotreatment1
ferrous chloridedecreases expression1
beta-methylcholineaffects expression1
pentabromodiphenyl etherdecreases expression1
Temozolomideincreases expression1
Endosulfandecreases expression1
Manganeseincreases abundance, increases expression, affects cotreatment1
Ozoneaffects expression, increases abundance1
Quercetindecreases expression1
Silicon Dioxideincreases expression1
Smokedecreases expression, increases abundance1
Tobacco Smoke Pollutiondecreases expression1
Urethanedecreases expression1
Zincdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.